Trial of Rifaximin in the Treatment of Tropical Enteropathy

The Washington University logo

The Washington University

Status

Completed

Conditions

Tropical Enteropathy

Treatments

Drug: Rifaximin
Drug: Placebo

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT00858988
MJM-rifaximin

Details and patient eligibility

About

The purpose of this study is to determine whether rifaximin is effective in the treatment of tropical enteropathy in a population of African children at high risk for this disease.

Enrollment

147 patients

Sex

All

Ages

3 to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • live in single village

Exclusion criteria

  • acutely malnourished
  • acutely ill
  • chronic disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

147 participants in 2 patient groups, including a placebo group

Rifaximin
Experimental group
Treatment:
Drug: Rifaximin
Placebo
Placebo Comparator group
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems